{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:54:38Z","timestamp":1785192878354,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of the study was to provide an overview of the practices of French general dentists (GDs) and specialists (SDs) concerning the management of patients with inflammatory bowel diseases (IBDs), rheumatic inflammatory diseases (IRDs), and vasculitis on biologic disease-modifying antirheumatic drugs (bDMARDs), conventional DMARDs, or immunosuppressants (ISs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>An online national cross-sectional survey with 53 questions was developed by a multidisciplinary team including rheumatologists, gastroenterologists and dentists based on their clinical experience. It was refined following a test with nine dentists in private practice and in hospital before being disseminated to the members of French scientific societies and colleges of dentistry teachers over 3 months. Responses of general dentists versus specialists were compared with respect to their experience in managing patients with IRDs or IBDs, knowledge\/training, type of invasive procedure performed, management of medical treatment, perioperative oral-care protocols, and frequency of postoperative complications after invasive dental care procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>In total, 105 practitioners fully completed the survey (participation rate 11.1%). SDs more frequently performed invasive surgical procedures and were more aware of the recommendations of learned societies than GDs. They encountered more post-operative complications for patients on bDMARDs. For both SDs and GDs, most patients were managed without stopping treatment and pre- and postoperative antibiotics were prescribed to more than 75% of patients. When medical treatment was stopped, the decision was made by the prescribing physician.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Complications were reported more frequently by SDs when highly invasive procedures were performed on patients under active drug therapy. Certain common procedures, such as scaling and root planing, appear to be safe, regardless of treatment management. However, adapted guidelines for the practice of dentistry are needed to standardize the management of patients on bDMARDS, conventional DMARDs, or ISs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical relevance<\/jats:title>\n                    <jats:p>French dentists perform a wide range of oral procedures on patients on bDMARDS, conventional DMARDs, or ISs under antibiotic coverage and antiseptic mouthwashes. SDs reported more postoperative complications after extensive invasive procedures for patients under active drug therapy, despite their greater knowledge of recommendations on how to manage such patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12903-023-03258-7","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T06:02:05Z","timestamp":1691560925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Management of dental care of patients on immunosuppressive drugs for chronic immune-related inflammatory diseases: a survey of French dentists\u2019 practices"],"prefix":"10.1186","volume":"23","author":[{"given":"Alice","family":"Bourgoin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevimy","family":"Agossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaele","family":"Seror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathurin","family":"Fumery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Radoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolaine","family":"Gosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"issue":"7","key":"3258_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/odi.12428","volume":"22","author":"LJ Jin","year":"2016","unstructured":"Jin LJ, et al. Global burden of oral diseases: emerging concepts, management and interplay with systemic health. Oral Dis. 2016;22(7):609\u201319.","journal-title":"Oral Dis"},{"key":"3258_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.diabres.2017.12.001","volume":"137","author":"M Sanz","year":"2018","unstructured":"Sanz M, et al. Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International diabetes Federation and the European Federation of Periodontology. Diabetes Res Clin Pract. 2018;137:231\u201341.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"3258_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/jcpe.13189","volume":"47","author":"M Sanz","year":"2020","unstructured":"Sanz M, et al. Periodontitis and cardiovascular diseases: consensus report. J Clin Periodontol. 2020;47(3):268\u201388.","journal-title":"J Clin Periodontol"},{"key":"3258_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3899\/jrheum.091461","volume":"85","author":"H El-Gabalawy","year":"2010","unstructured":"El-Gabalawy H, Guenther LC, Bernstein CN. Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J Rheumatol Suppl. 2010;85:2\u201310.","journal-title":"J Rheumatol Suppl"},{"issue":"10086","key":"3258_CR5","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389(10086):2328\u201337.","journal-title":"Lancet"},{"issue":"3","key":"3258_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1051\/mbcb\/2012027","volume":"18","author":"OraleSFdC","year":"2012","unstructured":"OraleSFdC. Prise en charge des foyers infectieux bucco-dentaires. Med Buccale Chir Buccale. 2012;18(3):251\u2013314.","journal-title":"Med Buccale Chir Buccale"},{"key":"3258_CR7","unstructured":"CRI. Available from: http:\/\/www.cri-net.com\/fiches-pratiques-et-eSessions\/dernieres-mises-a-jour."},{"key":"3258_CR8","unstructured":"ANSM. Available from: https:\/\/ansm.sante.fr\/documents\/reference\/medicaments-biosimilaires."},{"issue":"4","key":"3258_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jbspin.2006.04.001","volume":"73","author":"B Fautrel","year":"2006","unstructured":"Fautrel B, et al. Recommendations of the French Society for Rheumatology. TNFalpha antagonist therapy in rheumatoid arthritis. Joint Bone Spine. 2006;73(4):433\u201341.","journal-title":"Joint Bone Spine"},{"issue":"3","key":"3258_CR10","first-page":"152","volume":"115","author":"J Demoersman","year":"2014","unstructured":"Demoersman J, et al. Managing patients with therapeutic antibodies in odontostomatology. Rev Stomatol Chir Maxillofac Chir Orale. 2014;115(3):152\u201363.","journal-title":"Rev Stomatol Chir Maxillofac Chir Orale"},{"issue":"8","key":"3258_CR11","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/art.40149","volume":"69","author":"SM Goodman","year":"2017","unstructured":"Goodman SM, et al. 2017 American College of Rheumatology\/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Rheumatol. 2017;69(8):1538\u201351.","journal-title":"Arthritis Rheumatol"},{"key":"3258_CR12","doi-asserted-by":"publisher","unstructured":"Saunders NE, et al. Perioperative management of antirheumatic medications in patients with RA and SLE undergoing elective foot and ankle surgery: a critical analysis review. JBJS Rev. 2021;9(6). https:\/\/doi.org\/10.2106\/JBJS.RVW.20.00201.","DOI":"10.2106\/JBJS.RVW.20.00201"},{"issue":"2","key":"3258_CR13","first-page":"115","volume":"75","author":"N Hitomi","year":"2021","unstructured":"Hitomi N, et al. Awareness of complications of dental treatment in patients treated with drugs affecting the immune system: a nationwide questionnaire survey of dental practitioners in Japan. Acta Med Okayama. 2021;75(2):115\u201323.","journal-title":"Acta Med Okayama"},{"issue":"11","key":"3258_CR14","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/JPER.18-0658","volume":"90","author":"H Askar","year":"2019","unstructured":"Askar H, et al. Incidence and severity of postoperative complications following oral, periodontal, and implant surgeries: a retrospective study. J Periodontol. 2019;90(11):1270\u20138.","journal-title":"J Periodontol"},{"issue":"10","key":"3258_CR15","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jcpe.12455","volume":"42","author":"E Gaudin","year":"2015","unstructured":"Gaudin E, et al. Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis. J Clin Periodontol. 2015;42(10):922\u201332.","journal-title":"J Clin Periodontol"},{"issue":"1","key":"3258_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.joms.2016.07.019","volume":"75","author":"TL Aghaloo","year":"2017","unstructured":"Aghaloo TL, Tetradis S. Osteonecrosis of the jaw in the absence of antiresorptive or antiangiogenic exposure: a series of 6 cases. J Oral Maxillofac Surg. 2017;75(1):129\u201342.","journal-title":"J Oral Maxillofac Surg"},{"key":"3258_CR17","first-page":"2856926","volume":"2016","author":"A Cassoni","year":"2016","unstructured":"Cassoni A, et al. Adalimumab: another medication related to osteonecrosis of the jaws? Case Rep Dent. 2016;2016:2856926.","journal-title":"Case Rep Dent"},{"key":"3258_CR18","unstructured":"Dentistes ONdC. Available from: https:\/\/www.ordre-chirurgiens-dentistes.fr\/cartographie\/."},{"issue":"12","key":"3258_CR19","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1007\/s00784-019-02877-1","volume":"23","author":"L Radoi","year":"2019","unstructured":"Radoi L, et al. Perioperative management of oral anticoagulated patients undergoing an oral, implant, or periodontal procedure: a survey of practices of members of two dental scientific societies, the PRADICO study. Clin Oral Investig. 2019;23(12):4311\u201323.","journal-title":"Clin Oral Investig"},{"key":"3258_CR20","unstructured":"sant\u00e9 Mdl. D\u00e9mographie des chirurgiends-dentistes. 2021."}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-03258-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-023-03258-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-03258-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T01:17:38Z","timestamp":1700529458000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-023-03258-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3258"],"URL":"https:\/\/doi.org\/10.1186\/s12903-023-03258-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2451141\/v1","asserted-by":"object"}]},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"6 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was granted by the APHP Centre Research Ethics Committee on June 15, 2020, and is registered under IRB registration number: #00011928. Before answering the survey, all subjects gave their informed consent. All the methods were carried out in accordance to relevant guideline and regulation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"545"}}